All Stories

  1. Liver tissue microbiota linked to nonalcoholic fatty liver disease
  2. Obstructive Sleep Apnea Is Associated with Fatty Liver and Abnormal Liver Enzymes: a Meta-analysis
  3. Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease
  4. Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: A new endocrine system in metabolic syndrome
  5. Epigenetics of Insulin Resistance: An Emerging Field in Translational Medicine
  6. Fetal metabolic programming and epigenetic modifications: a systems biology approach
  7. Maternal high-fat intake during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A
  8. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model
  9. Cardiovascular phenotype of nonalcoholic fatty liver disease: Hanging the paradigm about the role of distant toxic fat accumulation on vascular disease
  10. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
  11. The Genetic Epidemiology of Nonalcoholic Fatty Liver Disease
  12. DNA methylation and hepatic insulin resistance and steatosis
  13. Alanine and aspartate aminotransferase and glutamine-cycling pathway: Their roles in pathogenesis of metabolic syndrome
  14. Genetic determinants of acquired cholestasis: A systems biology approach
  15. PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease
  16. Targeting the renin-angiotensin system: Potential beneficial effects of the angiotensin II receptor blockers in patients with nonalcoholic steatohepatitis
  17. Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
  18. Mitochondrial DNA copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3)
  19. Cyclooxygenase inhibition Up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liver
  20. Reply:
  21. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
  22. Odor perception between heterosexual partners: Its association with depression, anxiety, and genetic variation in odorant receptor OR7D4
  23. Cardiac Thyrotropin-Releasing Hormone Mediates Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats
  24. Loci From a Genome-Wide Analysis of Bilirubin Levels Are Associated With Gallstone Risk and Composition
  25. Metabolic Syndrome: From the Genetics to the Pathophysiology
  26. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter
  27. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia
  28. GENE-GENE INTERACTION BETWEEN SEROTONIN TRANSPORTER (SLC6A4) ANDCLOCKMODULATES THE RISK OF METABOLIC SYNDROME IN ROTATING SHIFTWORKERS
  29. Increased levels of resistin in rotating shift workers: A potential mediator of cardiovascular risk associated with circadian misalignment
  30. Letter by Landa et al Regarding Article, “Protein Tyrosine Phosphatase 1B, a Major Regulator of Leptin-Mediated Control of Cardiovascular Function”
  31. Methylation of TFAM gene promoter in peripheral white blood cells is associated with insulin resistance in adolescents
  32. Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease
  33. The influence of common gene variants of the xenobiotic receptor(PXR)in genetic susceptibility to intrahepatic cholestasis of pregnancy
  34. Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension
  35. Influence of hepatocyte nuclear factor 4α (HNF4α) gene variants on the risk of type 2 diabetes: A meta-analysis in 49,577 individuals
  36. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease
  37. The impact of maternal high-fat feeding on liver and abdominal fat accumulation in adult offspring under a long-term high-fat diet
  38. Shift work and subclinical atherosclerosis: Recommendations for fatty liver disease detection
  39. Genetic Variation in the FAAH Gene and Metabolic Syndrome–related Phenotypes
  40. Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease
  41. Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model
  42. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
  43. A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem
  44. Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with type 2 diabetes
  45. Maternal Pregestational BMI Is Associated With Methylation of thePPARGC1APromoter in Newborns
  46. Angiotensin-(1-7) through AT2receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway
  47. Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease
  48. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review
  49. A Decreased Mitochondrial DNA Content Is Related to Insulin Resistance in Adolescents
  50. Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes
  51. Study of Genetic Variation in theSTAT3on Obesity and Insulin Resistance in Male Adults
  52. Should Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects: Response to Musso et al.
  53. Contribution of the Functional 5-HTTLPR Variant of the SLC6A4 Gene to Obesity Risk in Male Adults
  54. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy
  55. Role of ABCC2 common variants in intrahepatic cholestasis of pregnancy
  56. Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin
  57. Review: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications
  58. Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat
  59. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation
  60. Short Allele of Serotonin Transporter Gene Promoter Is a Risk Factor for Obesity in Adolescents*
  61. Association of the C−344T aldosterone synthase gene variant with essential hypertension: a meta-analysis
  62. SiRNA-mediated silencing of the diencephalic thyrotropin-releasing hormone precursor gene decreases the arterial blood pressure in the obese agouti mice
  63. Mitochondrial DNA Depletion in Small- and Large-for-Gestational-Age Newborns*
  64. Integrative study of hypothalamus–pituitary–thyroid–immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway
  65. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents
  66. The G-308A Promoter Variant of the Tumor Necrosis Factor-α Gene Is Associated With Hypertension in Adolescents Harboring the Metabolic Syndrome
  67. Low Mpl receptor expression in a pedigree with familial platelet disorder with predisposition to acute myelogenous leukemia and a novel AML1 mutation
  68. Thyrotropin-releasing hormone in cardiovascular pathophysiology
  69. Parathyroid Hormone-Related Protein Overexpression Decreases Blood Pressure in Spontaneously Hypertensive Rats
  70. A1166C Angiotensin II Type 1 Receptor Gene Polymorphism May Predict Hemodynamic Response to Losartan in Patients with Cirrhosis and Portal Hypertension
  71. PDGF-A, PDGF-B, TGF?, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide
  72. Normal platelets possess the soluble form of IL-6 receptor
  73. Clinical Features of the Metabolic Syndrome in Adolescents: Minor Role of the Trp64Arg β3-Adrenergic Receptor Gene Variant
  74. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension
  75. Renin–Angiotensin–Aldosterone System Loci and Multilocus Interactions in Young‐Onset Essential Hypertension
  76. Thyrotropin-Releasing Hormone Decreases Leptin and Mediates the Leptin-Induced Pressor Effect
  77. Parathyroid hormone-related protein expression in vascular smooth muscle of spontaneously hypertensive rats
  78. Angiotensin II enhances long-term memory in the crab Chasmagnathus
  79. Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: cell-specific regulation by angiotensin- II and PTHrP
  80. Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro
  81. Effects of N-terminal, midregion, and C-terminal parathyroid hormone- related peptides on adenosine 3',5'-monophosphate and cytoplasmic free calcium in rat aortic smooth muscle cells and UMR-106 osteoblast-like cells
  82. Brain amines in glucocorticoid-induced hypertension in the rat
  83. The cholinergic system participates in thyrotropin-releasing hormone (TRH) regulation
  84. Cholinergic hyperactivity in the lateral septal area of spontaneously hypertensive rats: Depressor effect of hemicholinium-3 and pirenzepine
  85. Increase in muscarinic receptors in rat intestine by Thyrotropin Releasing Hormone (TRH)
  86. Thyrotropin-releasing hormone increases the number of muscarinic receptors in the lateral septal area of the rat brain
  87. Serotonergic and noradrenergic mechanisms involved in the cardiovascular effects of angiotensin II injected into the anterior hypothalamic preoptic region of rats